Pure Global

PIMR and Pulmonary Vascular Disease - Trial NCT05843461

Access comprehensive clinical trial information for NCT05843461 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Los Angeles and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05843461
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05843461
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
PIMR and Pulmonary Vascular Disease
The Pulmonary Index of Microcirculatory Resistance: A Novel Hemodynamic Index for Invasively Assessing the Pulmonary Vasculature

Study Focus

Pulmonary Hypertension

Pulmonary Index of Microcirculatory Resistance

Observational

other

Sponsor & Location

University of California, Los Angeles

Los Angeles, United States of America

Timeline & Enrollment

N/A

Jan 10, 2023

Apr 30, 2024

30 participants

Primary Outcome

Pulmonary Index of Microcirculatory Resistance (PIMR),Right Ventricle Index of Microcirculatory Resistance (RV-IMR),OCT-derived pulmonary artery wall thickness,OCT-derived thickness-diameter ratio,OCT-derived wall-area ratio

Summary

The findings from this innovative, first-in-man, prospective pilot study will elucidate the
 role of PIMR and RV-IMR in pre-capillary PH. The study cohort will consist of patients with
 pulmonary pressures ranging from normal (advanced lung disease patients undergoing lung
 transplant evaluation) to severe PH (PAH and CTEPH patients), and thus will allow for
 identification of a PIMR cutoff. Participants will include: 1) advanced lung disease patients
 undergoing bilateral heart catheterization as part of their pre-lung transplant work-up, and
 2) newly referred patients to PAH and CTEPH clinics undergoing bilateral heart
 catheterization as part of standard of care work-up. All participants will undergo PIMR
 testing, and those with pre-capillary PH will also undergo pulmonary OCT and measurement of
 RV-IMR. The study seeks to define the relationship between PIMR and PH and to establish the
 PIMR threshold that identifies pulmonary microvascular dysfunction as well as to evaluate the
 association of PIMR and pulmonary vascular remodeling on OCT in patients with pre-capillary
 PH. In addition, the study will assess the relationship between RV-IMR and RV pressure
 overload among patients with pre-capillary PH.

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Pulmonary heart disease, unspecified
Pulmonary valve disorders

Data Source

ClinicalTrials.gov

NCT05843461

Non-Device Trial